To the Editor In the last 3 decades, several randomized clinical trials (RCTs) have compared percutaneous coronary interventions (PCIs) with coronary artery bypass grafting (CABG) for the revascularization of patients with coronary artery disease (CAD). In the meta-analysis by Gaudino and colleagues,1 the authors pooled 23 RCTs and concluded that PCI was associated with higher 5-year cardiac as well as noncardiac mortality.